Methods for Assessing Improvement in Specificity When a Biomarker is Combined With a Standard Screening Test
- 1 February 2009
- journal article
- Published by Taylor & Francis in Statistics in Biopharmaceutical Research
- Vol. 1 (1) , 18-25
Abstract
Biomarkers that can be used in combination with established screening tests to reduce false positive rates are in considerable demand. In this article, we present methods for evaluating the diagnos...Keywords
This publication has 18 references indexed in Scilit:
- Strategies Combining Total and Percent Free Prostate Specific Antigen for Detecting Prostate Cancer: A Prospective EvaluationJournal of Urology, 2002
- Comparing disease screening tests when true disease status is ascertained only for screen positivesBiostatistics, 2001
- Ten-Year Risk of False Positive Screening Mammograms and Clinical Breast ExaminationsNew England Journal of Medicine, 1998
- Comparison of the Accuracy of Two Tests with a Confirmatory Procedure Limited to Positive ResultsEpidemiology, 1997
- Analysis of percent free prostate-specific antigen (PSA) for prostate cancer detection: Influence of total psa, prostate volume, and ageUrology, 1996
- Evaluation of percentage of free serum prostate-specific antigen to improve specificity of prostate cancer screening1995
- Positive predictive value of screening mammography by age and family history of breast cancer1993
- The Predictive Value of Simple Rules for Combining Two Diagnostic TestsBiometrics, 1989
- A randomized trial of aspirin and β-carotene among U.S. physiciansPreventive Medicine, 1985
- Maximum-likelihood estimation of parameters of signal-detection theory and determination of confidence intervals—Rating-method dataJournal of Mathematical Psychology, 1969